Percutaneous Aortic Valve Bioprosthesis Implantation
نویسندگان
چکیده
منابع مشابه
[Transcatheter aortic valve-in-valve implantation for failed aortic bioprosthesis].
Percutaneous valve replacement for severe aortic stenosis has been shown to be an alternative treatment option for high surgical risk patients. We describe our first valve-in-valve procedure in a patient with a degenerated aortic bioprosthesis and severe regurgitation.
متن کاملSuccessful percutaneous coronary intervention after transcatheter aortic valve implantation with CoreValve bioprosthesis
We present a case of an 84-year-old male patient who was admitted to our department due to recurrent angina 17 months after transcatheter aortic valve implantation (TAVI) with a 29 mm CoreValve bioprosthesis (Figure 1). Symptoms were increasing in the past several weeks, and on admission the patient was in Canadian Cardiovascular Society class 3. His past medical history included hypertension a...
متن کاملPercutaneous aortic valve replacement with the CoreValve bioprosthesis.
e read with interest the recent article of Grube et al. (1) dealing ith percutaneous aortic valve implantation. They reported the xperience from 3 centers using the second and third generations f the CoreValve prosthesis (CoreValve Inc., Irvine, California) in 6 consecutive patients. The acute device success was high (88%), nd the 30-day mortality was low (12%) in these surgically igh-risk pati...
متن کاملPercutaneous aortic valve implantation: the anesthesiologist perspective
Percutaneous aortic valve implantation is an emergent technique alternative to surgical aortic valve replacement in high risk patients with aortic stenosis. Percutaneous aortic valve implantation techniques are undergoing rapid development and currently represent a dynamic field of research. Perioperative optimal strategies keep on evolving too. At a review of the literature, only three previou...
متن کاملIndication for percutaneous aortic valve implantation
The incidence of valvular aortic stenosis has increased over the past decades due to improved life expectancy. Surgical aortic valve replacement is currently the only treatment option for severe symptomatic aortic stenosis that has been shown to improve survival. However, up to one third of patients who require lifesaving surgical aortic valve replacement are denied surgery due to high comorbid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Cardiovascular Sciences
سال: 2015
ISSN: 2359-4802
DOI: 10.5935/2359-4802.20150051